Excess respiratory mortality and hospitalizations associated with influenza in Australia, 2007-2015.

BACKGROUND Influenza is the most common vaccine-preventable disease in Australia, causing significant morbidity and mortality. We assessed the burden of influenza across all ages in terms of influenza-associated mortality and hospitalizations using national mortality, hospital-discharge and influenza surveillance data. METHODS Influenza-associated excess respiratory mortality and hospitalization rates from 2007 to 2015 were estimated using generalized additive models with a proxy of influenza activity based on syndromic and laboratory surveillance data. Estimates were made for each age group and year. RESULTS The estimated mean annual influenza-associated excess respiratory mortality was 2.6 per 100 000 population [95% confidence interval (CI): 1.8, 3.4 per 100 000 population]. The excess annual respiratory hospitalization rate was 57.4 per 100 000 population (95% CI: 32.5, 82.2 per 100 000 population). The highest mortality rates were observed among those aged ≥75 years (35.11 per 100 000 population; 95% CI: 19.93, 50.29 per 100 000 population) and hospitalization rates were also highest among older adults aged ≥75 years (302.95 per 100 000 population; 95% CI: 144.71, 461.19 per 100 000 population), as well as children aged <6 months (164.02 per 100 000 population; 95% CI: -34.84, 362.88 per 100 000 population). Annual variation was apparent, ranging from 1.0 to 3.9 per 100 000 population for mortality and 24.2 to 94.28 per 100 000 population for hospitalizations. Influenza A contributed to almost 80% of the average excess respiratory hospitalizations and 60% of the average excess respiratory deaths. CONCLUSIONS Influenza causes considerable burden to all Australians. Expected variation was observed among age groups, years and influenza type, with the greatest burden falling to older adults and young children. Understanding the current burden is useful for understanding the potential impact of mitigation strategies, such as vaccination.

[1]  David L. Smith,et al.  Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017 , 2019, The Lancet Respiratory Medicine.

[2]  Eyal Oren,et al.  Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet. Infectious diseases.

[3]  E. Lau,et al.  Heterogeneity in Estimates of the Impact of Influenza on Population Mortality: A Systematic Review , 2018, American journal of epidemiology.

[4]  Jan Kyncl,et al.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study , 2017, The Lancet.

[5]  D. Muscatello,et al.  Influenza‐associated mortality in South Africa, 2009‐2013: The importance of choices related to influenza infection proxies , 2017, Influenza and other respiratory viruses.

[6]  N. Stocks,et al.  Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  D. Muscatello,et al.  Emergency Department demand associated with seasonal influenza, 2010 through 2014, New South Wales, Australia , 2017, Western Pacific surveillance and response journal : WPSAR.

[8]  N. de Klerk,et al.  Epidemiology of seasonal influenza infection in pregnant women and its impact on birth outcomes , 2017, Epidemiology and Infection.

[9]  G. Kusznierz,et al.  Impact of influenza in the post‐pandemic phase: Clinical features in hospitalized patients with influenza A (H1N1) pdm09 and H3N2 viruses, during 2013 in Santa Fe, Argentina , 2017, Journal of medical virology.

[10]  E. Lau,et al.  A joint analysis of influenza-associated hospitalizations and mortality in Hong Kong, 1998–2013 , 2017, Scientific Reports.

[11]  A. Cheng,et al.  Influenza hospitalizations in Australian children , 2017, Epidemiology and Infection.

[12]  S. Omer,et al.  Effect of Maternal Influenza Vaccination on Hospitalization for Respiratory Infections in Newborns: A Retrospective Cohort Study , 2016, The Pediatric infectious disease journal.

[13]  N. Stocks,et al.  Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment. , 2016, Vaccine.

[14]  C. Dalton,et al.  How severe was the 2015 influenza season in Australia? , 2016, The Medical journal of Australia.

[15]  I. Barr,et al.  Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[16]  M. Lipsitch,et al.  Estimating the hospitalization burden associated with influenza and respiratory syncytial virus in New York City, 2003–2011 , 2015, Influenza and other respiratory viruses.

[17]  J. Bresee,et al.  Burden of influenza-associated deaths in the Americas, 2002–2008 , 2015, Influenza and other respiratory viruses.

[18]  Ivo M Foppa,et al.  Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14☆ , 2015, Vaccine.

[19]  H. Kelly,et al.  Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia. , 2015, Vaccine.

[20]  Mark Jit,et al.  The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. , 2014, The Journal of infection.

[21]  Peng Wu,et al.  Excess mortality impact of two epidemics of pandemic influenza A(H1N1pdm09) virus in Hong Kong , 2013, Influenza and other respiratory viruses.

[22]  M. Meltzer,et al.  Influenza cost and cost-effectiveness studies globally--a review. , 2013, Vaccine.

[23]  D. Gravel,et al.  Understanding the burden of influenza infection among adults in Canadian hospitals: a comparison of the 2009-2010 pandemic season with the prepandemic and postpandemic seasons. , 2013, American journal of infection control.

[24]  C. Macintyre,et al.  Mortality Attributable to Seasonal and Pandemic Influenza, Australia, 2003 to 2009, Using a Novel Time Series Smoothing Approach , 2013, PloS one.

[25]  Peng Wu,et al.  Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. , 2012, The Journal of infectious diseases.

[26]  Cecile Viboud,et al.  Improving the Estimation of Influenza-Related Mortality Over a Seasonal Baseline , 2012, Epidemiology.

[27]  H. Kelly,et al.  Effectiveness of Seasonal Influenza Vaccine against Pandemic (H1N1) 2009 Virus, Australia, 2010 , 2011, Emerging infectious diseases.

[28]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[29]  C. Viboud,et al.  Influenza-attributable mortality in Australians aged more than 50 years: a comparison of different modelling approaches , 2009, Epidemiology and Infection.

[30]  Lynnette Brammer,et al.  Estimates of US influenza‐associated deaths made using four different methods , 2009, Influenza and other respiratory viruses.

[31]  P. Scuffham,et al.  Influenza-related disease: the cost to the Australian healthcare system. , 2008, Vaccine.

[32]  I. Barr,et al.  Annual report of the National Influenza Surveillance Scheme, 2007. , 2008, Communicable diseases intelligence quarterly report.

[33]  K. D'onise,et al.  The burden of influenza in healthy children in South Australia , 2008, The Medical journal of Australia.

[34]  C. Macintyre,et al.  Influenza-related hospitalisation and death in Australians aged 50 years and older , 2008, Vaccine.

[35]  C. Bridges,et al.  Influenza- and RSV-associated hospitalizations among adults. , 2007, Vaccine.

[36]  Lin Yang,et al.  Influenza-Associated Hospitalization in a Subtropical City , 2006, PLoS medicine.